Skip to main content

Table 1 Patient characteristics: (y) years; (n) number

From: Accelerated hypofractionated radiotherapy plus chemotherapy for inoperable locally advanced non-small-cell lung cancer: final results of a prospective phase-II trial with a long-term follow-up

Characteristic

Value y, n (%)

Age (y)

 Median

58

 Range

43–69

Gender (n)

 Male

13 (76)

 Female

4 (24)

Histologic subtype (n)

 Adenocarcinoma

10 (59)

 Squamous cell carcinoma

7 (4)

Clinical Stage (n)

 Tumor classification (TNM 7th ed.)

  T2

3 (18)

  T3

1 (6)

  T4

13 (76)

 Lymph node status (n)

  N2 (multistation)

11 (65)

  N3

6 (35)

  IIIA

2 (12)

  IIIB

15 (88)

 Chemotherapy regimen (n)

 Cisplatin/Docetaxel

17 (100)

Clinical re-staging (n)

 Tumor classification (n)

  T0

4 (23)

  T1

1 (6)

  T2

3 (18)

  T4

9 (53)

 Lymph node re-staging (n)

  N0

12 (70)

  N2

3 (18)

  N3

2 (12)

  1. TNM Staging system 7th Edition used to classify tumors